Fasikl Secures $5M in Pre-A Investment

(MINNEAPOLIS, Minn.) November 1, 2021 – Fasikl has closed a $5 million Pre- Series A equity investment to accelerate its R&D in AI-driven therapeutic technologies. The funding will support continued research and development and launch a pilot clinical trial to establish a regulatory pathway for AI-based therapeutics.